Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5857698 | Regulatory Toxicology and Pharmacology | 2013 | 10 Pages |
Abstract
⺠Low dose villages defined by median (but not by mean or maximum) includes arsenic levels >500 μg/L. ⺠Dose-response slopes for villages with only low (<150 μg/L) arsenic levels are negative and often significantly. ⺠Inclusion of reference population at 0 μg/L forces a positive slope. ⺠Blackfoot disease (BFD) area is unique; sources of risk are not limited to arsenic. ⺠EPA model ignores both high arsenic and non-arsenic as explanatory risk factors.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Steven H. Lamm, Shayhan A. Robbins, Chao Zhou, Jun Lu, Rusan Chen, Manning Feinleib,